AWF
ADPT icon

Alpha Wealth Funds’s Adaptive Biotechnologies ADPT Stock Holding History

Alpha Wealth Funds’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,000
Closed -$297K – 48
2025
Q1 		$297K Buy
+40,000
New +$307K 0.3% 31

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alpha Wealth Funds's ADPT Position: Q2 2025 in Review

Alpha Wealth Funds sold out of Adaptive Biotechnologies (ADPT) in Q2 2025, closing a stake of 40,000 shares — an estimated $297K sold.

Alpha Wealth Funds first reported a position in ADPT in Q1 2025 and held it in 1 quarter. The position peaked at $297K in Q1 2025. 242 funds tracked by Wall St. Rank hold ADPT as of Q2 2025.

  • Alpha Wealth Funds reported no remaining Adaptive Biotechnologies position as of Q2 2025 after selling out during the quarter.
  • Alpha Wealth Funds sold 40,000 Adaptive Biotechnologies shares in Q2 2025, an estimated $297K.
  • Alpha Wealth Funds first reported a position in Adaptive Biotechnologies in Q1 2025 and held it in 1 quarter.
  • Alpha Wealth Funds's Adaptive Biotechnologies position peaked at $297K in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2025.

Based on Alpha Wealth Funds's 13F filing for Q2 2025, filed 29 Jul 2025.